Keyphrases
Therapeutic Agents
100%
RNA Interference
100%
COVID-19
100%
Inflammasome Activation
100%
Treatment Strategy
75%
Non-coding RNA (ncRNA)
75%
Effective Treatment
50%
MicroRNA
50%
COVID-19 Patients
50%
Inflammasome
50%
Immune Dysregulation
50%
Delivery System
25%
Nanomaterials
25%
Prevention Strategies
25%
Inflammatory Mediators
25%
Inflammatory Cytokines
25%
Vehicle Type
25%
Delivery Vehicle
25%
Drug Efficacy
25%
Efficient Delivery
25%
Putative Drug Targets
25%
SARS-CoV-2 Variants
25%
COVID-19 Treatment
25%
NLRP3 Inflammasome
25%
Poor Clinical Outcomes
25%
Associated Complications
25%
COVID-19 Pathogenesis
25%
NOD-like Receptor Protein 3 (NLRP3)
25%
Pre-clinical and Clinical Trials
25%
Cytokine Storm
25%
Interference Mechanism
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammasome
100%
microRNA
40%
Untranslated RNA
40%
Immune Dysregulation
40%
Clinical Trial
20%
SARS Coronavirus
20%
Long Untranslated RNA
20%
Cytokine
20%
Cytokine Storm
20%
Nanomaterial
20%